Lipocube Biotechnology

What Lipocube Biotechnology does

Lipocube Biotechnology is a UK-headquartered (London) medical device company that develops and sells mechanical systems for processing autologous fat tissue for regenerative medicine applications. Founded in 2020 by plastic surgeons Dr. Tunc Tiryaki and Dr. Steven R. Cohen, the company manufactures single-use devices — LipoCube Nano (micro/nano-fat processing), LipoCube SVF (Stromal Vascular Fraction isolation via the Cell-Drive centrifuge), and LipoCube Hybrid Mini (selective fat concentration) — that use patented structural-geometry blades and flow patterns inside closed sterile systems to mechanically process lipoaspirate without enzymatic digestion or GMP facilities. The portfolio is supplemented by disposable consumables (Nano Kit, PRP tubes), lipotransfer instruments, and accessories such as AdiFrost freezing containers.

The company sells capital equipment and consumables directly to specialist physicians — plastic surgeons, orthopedic surgeons, dermatologists, urologists, gynecologists, and wound-care specialists — across aesthetics, orthopedics, wound healing, urology, and gynecology applications. Distribution runs through a company e-commerce shop, direct sales via contact forms, and conference presence (IMCAS, FUE Europe), with the LipoCube Academy providing free online training to drive adoption. Recurring revenue is generated through single-use kits and consumables tied to device use.

LipoCube reports 199,000+ patients treated by 24,900+ physicians across 82 countries and holds FDA 510(k) clearance (BK220767), ANVISA approval in Brazil, and a first-in-Japan IV clinical approval for autologous SVF therapy (2025). The company is privately held with no disclosed funding rounds, operates regional offices in London and Istanbul, and has no public revenue or headcount disclosure.

Name

Lipocube Biotechnology

Legal name

LipoCube Company

Website

https://lipocube.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

11–50 employees

Short description

Lipocube Biotechnology is a UK-based medical device company that designs and sells mechanical fat-tissue processing systems — including LipoCube Nano, SVF, and Hybrid Mini — for specialist physicians in aesthetics, orthopedics, wound healing, urology, and gynecology worldwide.

Ownership category

akta.pro rank

Product category

Medical Devices for Regenerative Medicine

NAICS

Medical Equipment and Supplies Manufacturing (3391), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

3D Bioprinting & Biofabrication (HLAAAGAC)

akta.pro secondary industries

Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG), Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH)

Keywords

• Fat tissue processing devices
• Regenerative medicine equipment
• Medical devices aesthetics
• SVF isolation systems
• Plastic surgery instruments

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Sale of primary medical devices including LipoCube Nano, LipoCube SVF, and Hybrid Mini systems. These are capital equipment devices sold to medical practices and hospitals for fat tissue processing procedures.
2. Disposable Consumables: Single-use kits and consumables including Nano Kit, PRP Tubes, Lipotransfer Devices, and accessories. These create recurring revenue as procedures are performed.
3. Accessories and Peripheral Equipment: Sale of supporting equipment including Cell Drive centrifuges, LipoGuide harvesters, Syringe Locks, stands, and specialized containers like AdiFrost freezing containers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

LipoCube Biotechnology manufactures and sells single-use mechanical medical devices that process autologous fat tissue into micro-fat, nano-fat, and stromal vascular fraction (SVF) for regenerative medicine applications. Its portfolio includes the LipoCube Nano (micro/nano fat processing), LipoCube SVF (mechanical SVF isolation), LipoCube Hybrid Mini (selective filtration), the Nano Kit, PRP kits, Lipotransfer Devices, and supporting accessories. The devices use patented structural geometry blades, flow patterns, and a cell-attracting trap within a closed sterile system, enabling clinic-based regenerative treatments in aesthetics, orthopedics, wound healing, urology, and gynecology without requiring GMP facilities.

Product overview

Lipocube Biotechnology is a UK-based medical device company specializing in regenerative medicine based on human fat tissue processing. The product portfolio centers on LipoCube devices that mechanically process adipose tissue for fat grafting and stem cell applications. The core offerings include LipoCube Nano (micro/nano-fat processing), LipoCube SVF (Stromal Vascular Fraction isolation), and LipoCube Hybrid Mini (selective fat concentration), supplemented by the Nano Kit (all-in-one harvesting kit), PRP kits, Biocream skincare product, Lipotransfer Devices, and various accessories. These products serve medical applications in aesthetics, orthopedics, wound healing, urology, and gynecology through a closed sterile mechanical processing system that enables clinic-based regenerative treatments without requiring GMP facilities.

Differentiator

Problem solved

Functional benefit

Brands

• LipoCube Academy: A free online academy for Health Care Professionals to obtain further experience and broaden their professional knowledge.

Products and services

• LipoCube Nano Single-use mechanical medical device for processing autologous lipoaspirate (fat tissue) into micro-fat and nano-fat graft for regenerative purposes. Uses patented specific structural geometry blades coupled with flow pattern enabling partial filtration of fibrous material, producing maximum 30ml nano fat and 120ml micro fat. For healthcare professionals performing fat grafting procedures.
• LipoCube SVF Medical device for mechanical isolation of Stromal Vascular Fraction (SVF) from lipoaspirate. Uses patented structural geometry blades with flow pattern and Cell-Drive technology with a patented cell-attracting trap to concentrate SVF containing stem cells, endothelial cells, and pericytes. For healthcare professionals performing regenerative therapies in aesthetics, orthopedics, and wound healing.
• LipoCube Hybrid Mini Selective filtration technology that condenses harvested fat tissue while removing blood, fat, fluid, and damaged cells within a closed sterile system. Uses mechanical digestion followed by centrifugation with specially designed LipoCube Centrifuge Containers; processes 40 cc adipose tissue in approximately 12 minutes. For healthcare professionals performing fat grafting procedures.
• LipoCube Nano Kit Disposable all-in-one kit for guided harvesting of autologous adipose tissue rich in stromal cells (SVF) containing Adipose-Derived Stem Cells (ADSCs). Includes all materials for harvesting and processing in a closed sterile environment without requiring additional equipment. For healthcare professionals performing regenerative procedures.
• LipoCube PRP (6 Tubes) PRP (Platelet Rich Plasma) medical kits designed for fast and efficient PRP separation using a closed sterile system. Available as 6-tube kit for applications in Anti-Ageing, Orthopedics, Urology, Diabetic Ulcers, Gynecology, Wound Care, and Dermatology. Class II B Approved. For healthcare professionals performing PRP-based regenerative procedures.
• Lipotransfer Devices Collection of devices for convenient fat harvesting, suction, and injection, including Heavy Duty Body Harvester, Neck Harvester, Stem Cell Harvester, Spoon Injector, and Liporoller. Available in various specifications for different body areas and procedures. For healthcare professionals performing fat harvesting and transfer.
• LipoCube Accessories Supporting equipment including Cell Drive Plus and Cell Drive Mini centrifuges, PRP Centrifuge, AdiFrost freezing containers for adipose tissue preservation, LipoGuide harvesting guidance device, and Syringe Lock/Stand/Bag Stand accessories. Used alongside LipoCube core devices by healthcare professionals for regenerative procedures.

Quantifiable outcome

• Processing capacity: 40cc adipose tissue in approximately 12 minutes with Hybrid Mini
• +3 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core and minor.

• Century Clinic (Japan)coreStrategic or Co-development Partner · 2 July 2025Century Clinic in Japan received clinical approval and completed Japan's first patient case using freshly harvested liposuction material processed with LipoCube technology for intravenous (IV) infusion. This marks the first-ever IV clinical approval and treatment in Japan utilizing LipoCube technology, establishing a landmark development for systemic application of autologous SVF therapy. LipoCube's closed-loop system guarantees maximum sterility, high cell viability, and consistent clinical performance.
• Cronos MedminorStrategic or Co-development PartnerCronos Med clinics collaborate with LipoCube for educational webinars and training on ADSC treatments in orthopedics. Dr. Laura Dospinescu, a specialist in regenerative medicine at Cronos Med, is part of the LipoCube advisory network.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Arthrex: Arthrex is a dominant orthopedic medical device incumbent with a growing orthobiologics and regenerative medicine portfolio, including PRP and adipose-derived therapies that overlap with Lipocube's orthopedic and PRP offerings.
• Vericel: Vericel is a commercial-stage cell therapy company marketing autologous cell-based products for cartilage repair and wound care, making it a broader incumbent in regenerative medicine with adjacent indications to Lipocube's orthopedics and wound healing segments.
• Cytori Therapeutics: Cytori has historically commercialized SVF-based cell therapy platforms for systemic and localized regenerative indications, making it a broader incumbent with overlapping technology and indications to Lipocube's SVF franchise.

Emerging players

• Regenexx: Regenexx provides autologous orthobiologic procedures including adipose- and bone-marrow-derived cell therapies for musculoskeletal conditions, overlapping with Lipocube's orthopedic SVF use case from a clinic-network rather than device-sales model.

Direct peers

• Tulip Medical Products: Tulip Medical supplies single-use fat harvesting, transfer, and injection devices used in liposuction and fat grafting procedures, competing with Lipocube's Lipotransfer Devices and Nano Kit in the surgical consumables category.
• GID Group: GID Group markets a mechanical SVF isolation platform for adipose-derived stem cells used by physicians in aesthetics and orthobiologics, making it the closest head-to-head competitor to LipoCube SVF in the same point-of-care regenerative medicine category.
• Tissue Genesis: Tissue Genesis produces automated cell isolation systems that process adipose tissue into regenerative cell populations, competing with Lipocube's mechanical SVF isolation devices in the same physician-administered regenerative medicine channel.
• InGeneron: InGeneron develops adipose-derived regenerative cell therapies and point-of-care processing systems for orthopedic and wound-healing applications, directly overlapping with Lipocube's orthopedic and wound-healing SVF use cases.
• MediKhan (LipiVage): MediKhan's LipiVage system is a closed sterile fat processing device that concentrates adipose tissue for autologous fat transfer, directly comparable to LipoCube Nano and Hybrid Mini in the fat-grafting device category.

Others

• PromoCell: PromoCell supplies primary human cells, cell culture media, and supporting reagents used in regenerative medicine research and clinical cell processing, representing an adjacent supplier ecosystem participant rather than a direct Lipocube competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/lipocube-biotechnology

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lipocube Biotechnology